METABOLIC EVALUATION OF PATIENTS WITH RECURRENT AND MULTIPLE RENAL STONES: A PROSPECTIVE STUDY
DOI:
https://doi.org/10.22159/ajpcr.2016.v9s3.14776Abstract
ABSTRACT
Objective: Renal stone disease has become an important clinical condition worldwide, and it results from a combination of several factors which
are biochemical, epidemiologic, and genetic in origin. Preventive measures are very important concerning stone disease and these measures greatly
depend on the type of stones. Performing a metabolic evaluation of stone patients to identify metabolic abnormality, if any, and treating the same helps
reduce the recurrence of stones. To identify and correct the metabolic risk factors of patients presenting with either recurrent, bilateral, or multiple
stones and thereby reduce the recurrence of stones.
Methods: A hospital-based prospective observational study, including collection of essential data of 100 patients and analyzing them for any metabolic
abnormality.
Results: Out of the 100 patients, 73 were males and 27 were females. The frequency of stone formation was high in the age group 51-60, even
though age is not a significant factor. Only 55 patients underwent metabolic evaluation, in which 23 patients (41.8%) had a metabolic abnormality.
The common abnormality found in this geographical area was hyperuricosuria (29.1%) followed by hypercalciuria (7.3%). Hypercalciuria was not
statistically significant, but hyperuricosuria and acidic urine pH were significant factors that contribute to stone formation.
Conclusion: Metabolic evaluation is a must for renal stone patients which greatly help reduce the risk of stone recurrence. Hyperuricemia was
observed to be the major abnormality followed by hypercalciuria. Acidic urine pH and low urine volume were other significant risk factors.
Keywords: Nephrolithiasis, Metabolic evaluation, Hyperuricosuria, Hypercalciuria.
Downloads
References
Kummer AE, Grams M, Lutsey P, Chen Y, Matsushita K, Köttgen A, et al. Nephrolithiasis as a risk factor for CKD: The atherosclerosis risk in communities study. Clin J Am Soc Nephrol 2015;10(11):2023-9.
Guy’s and St Thomas’ NHS Foundation Trust, 2014; Leaflet No. 2390/VER3.
Thorsten B, Murat B, Nicola D, Bente TJ, Thomas K, Andre M, et al. Patient information - Metabolic evaluation for kidney and ureteral stones. EAU 2012:1-2.
Al-Risi AO, Nida’a MA, Alka A. Study on prevalence and management of renal stones among Omani in-patients at Sohar hospital. SJAMS 2014;2(1A):22-33.
Andreas S, Michael S, Thomas K, Kemal S, Christian S, Ales P, et al. Metabolic Evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol 2015;67:750-63.
Paterson RF. Arguments for a comprehensive metabolic evaluation of the first-time stone former. Can Urol Assoc J 2010;4(3):209-10.
Joshi A, Gupta SK, Srivastava A. Metabolic evaluation in first-time renal stone formers in North India: A single center study. Saudi J Kidney Dis Transpl 2013;24(4):838-43.
Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005 26;293(4):455-62.
Charkhchian M, Samani S, Merat E. Clinical and metabolic evaluation of patients with history of renal calculi in Qazvin, Iran. Ir J Med Sci 2015;184(4):731-5.
Shekarriz B, Marshall LS. Metabolic evaluation of stone disease. Braz J Urol 2001;27(1):10-8.
Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: An update on current pharmacological management and future directions. Expert Opin Pharmacother 2013;14(4):435-47.
Goldfarb DS, Arowojolu O. Metabolic evaluation of first-time and recurrent stone formers. Urol Clin North Am 2013;40(1):13-20.
Krepinsky J, Ingram AJ, Churchill DN. Metabolic investigation of recurrent nephrolithiasis: Compliance with recommendations. Urology 2000;56(6):915-20.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
